Federal Register, Volume 85 Issue 195 (Wednesday, October 7, 2020)

[Federal Register Volume 85, Number 195 (Wednesday, October 7, 2020)]
[Notices]
[Pages 63277-63280]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22140]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2020-N-1720]

Labeling of Foods Comprised of or Containing Cultured Seafood
Cells; Request for Information

AGENCY: Food and Drug Administration, HHS.

[[Page 63278]]

ACTION: Notice; request for information.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or we) is requesting
information pertaining to the labeling of foods comprised of or
containing cultured seafood cells. Foods comprised of or containing
cultured seafood cells are being developed and may soon enter the
marketplace. Therefore, we intend to use information and data resulting
from this notice to determine what type(s) of action, if any, we should
take to ensure that these foods are labeled properly.

DATES: Submit either electronic or written comments on the notice by
March 8, 2021.

ADDRESSES: You may submit comments and information as follows. Please
note that late, untimely filed comments will not be considered.
Electronic comments must be submitted on or before March 8, 2021]. The
https://www.regulations.gov electronic filing system will accept
comments until 11:59 p.m. Eastern Time at the end of March 8, 2021.
Comments received by mail/hand delivery/courier (for written/paper
submissions) will be considered timely if they are postmarked or the
delivery service acceptance receipt is on or before that date.

Electronic Submissions

Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

Submit written/paper submissions as follows:
Mail/Hand delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2020-N-1720 for ``Labeling of Foods Comprised of or Containing
Cultured Seafood Cells; Request for Information.'' Received comments
will be placed in the docket and, except for those submitted as
``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m.
and 4 p.m., Monday through Friday, 240-402-7500.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' We will review
this copy, including the claimed confidential information, in our
consideration of comments. The second copy, which will have the claimed
confidential information redacted/blacked out, will be available for
public viewing and posted on https://www.regulations.gov. Submit both
copies to the Dockets Management Staff. If you do not wish your name
and contact information to be made publicly available, you can provide
this information on the cover sheet and not in the body of your
comments and you must identify this information as ``confidential.''
Any information marked as ``confidential'' will not be disclosed except
in accordance with 21 CFR 10.20 and other applicable disclosure law.
For more information about FDA's posting of comments to public dockets,
see 80 FR 56469, September 18, 2015, or access the information at:
https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852, 240-402-7500.

FOR FURTHER INFORMATION CONTACT: Andrea Krause, Center for Food Safety
and Applied Nutrition, Food and Drug Administration, 5001 Campus Dr.,
College Park, MD 20740, 240-402-2371.

SUPPLEMENTARY INFORMATION:

I. Background

A. FDA Jurisdiction Over Cultured Animal Cells

Efforts are underway to develop various food products comprised of
or containing cultured animal cells, including cells from livestock,
poultry, and seafood \1\ species, using a process often referred to as
animal cell culture technology. Animal cell culture technology involves
the controlled growth of animal cells, their subsequent differentiation
into various cell types, and their harvesting and processing into food.
Once produced, the harvested cells could potentially be processed into
or combined with other foods and marketed in the same, or similar,
manner as conventionally produced meat, poultry, and seafood. In this
document we refer to these foods as ``foods comprised of or containing
cultured animal cells.'' Many companies, both domestic and foreign, are
developing products using this technology. Given these technological
advances, it is appropriate to consider what actions, if any, may be
needed to ensure the safe production and accurate labeling of these
products.
---------------------------------------------------------------------------

\1\ The use of the term ``seafood'' refers to all fish
(freshwater and saltwater) and other seafood species (e.g.,
molluscs, crustaceans) under FDA jurisdiction.
---------------------------------------------------------------------------

FDA will be involved in the regulation of foods generated by animal
cell culture technology consistent with our current legal authorities.
We are responsible for implementing and enforcing the Federal Food,
Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 301 et seq.), the Public
Health Service Act (42 U.S.C. 201 et seq.), and the Fair Packaging and
Labeling Act (15 U.S.C. 1451 et seq.). In carrying out our
responsibilities under these laws, we maintain responsibility for
ensuring that food is safe and not misbranded.

B. Relevant Misbranding Provisions Under the FD&C Act

This document primarily pertains to representations about the
identity of foods comprised of or containing cultured seafood cells.
Such representations include the name of the food and descriptions
about its nature, source, or characteristics. There are

[[Page 63279]]

several provisions in the FD&C Act under which food may be misbranded
with respect to representations about identity. In general, the
representations made or suggested must not cause the labeling to be
misleading, either affirmatively or by omission of material facts (21
U.S.C. 343(a)(1) and 321(n)). The FD&C Act prohibits offering a food
for sale under the name of another food (21 U.S.C. 343(b)). It requires
the labels of non-standardized foods to bear the common or usual name
of the food if such a name exists (21 U.S.C. 343(i)(1)). Common or
usual names are generally established by common usage, though in some
cases may be established by regulation pursuant to the principles in 21
CFR 102.5(a)-(c) (see 21 CFR 102.5(d)). In the absence of a common or
usual name or other name established by federal law or regulation, food
sold in packaged form is required to be labeled with an accurate
description of the food or a fanciful name commonly used by the public
(Sec. 101.3(b)(3) (21 CFR 101.3(b)(3))). Such description or name must
not be false or misleading (21 U.S.C. 343(a)(1)) and is referred to as
the statement of identity (Sec. 101.3(b)). Finally, the FD&C Act
provides that words or statements required to appear on the label or
labeling be in such terms as to render them likely to be understood by
the ordinary individual under customary conditions of purchase and use
(21 U.S.C. 343(f)).

C. FDA-USDA Agreement Regarding Oversight of Human Food Produced Using
Animal Cell Technology Derived From Cell Lines of USDA-Amenable Species

In November 2018, FDA and the U.S. Department of Agriculture (USDA)
formally announced that they will jointly oversee the production of
cultured cell food products derived from livestock and poultry (Ref.
1). On March 7, 2019, FDA and USDA signed an agreement that described
each entity's intended roles with respect to the oversight of human
food produced using animal cell culture technology, derived from cell
lines of those species \2\ covered under the Federal Meat Inspection
Act (FMIA) (21 U.S.C. 601 et seq.) and the Poultry Products Inspection
Act (PPIA) (21 U.S.C. 451 et seq.) (Ref. 2). In summary, FDA will
oversee the collection, growth and differentiation of livestock and
poultry cells until cell harvest. A transition from FDA to USDA's Food
Safety and Inspection Service oversight will occur during the cell
harvest stage. USDA then will oversee the processing, packaging, and
labeling of the resulting food products derived from the cultured cells
of livestock and poultry. FDA will continue to regulate foods comprised
of or containing cultured animal cells from other species under FDA's
jurisdiction, such as seafood species other than Siluriformes fish.
---------------------------------------------------------------------------

\2\ Products made from cattle, sheep, swine, goats, and
Siluriformes fish are subject to the FMIA. Products made from
domesticated chickens, turkeys, ducks, geese, guineas, ratites, and
squab are subject to the PPIA.
---------------------------------------------------------------------------

In the FDA-USDA agreement, FDA and USDA have agreed to develop
joint principles for product labeling and claims to ensure that
products are labeled consistently and transparently.

D. Public Meetings on Animal Cell Culture Technology

Participation in public meetings is an important opportunity to
share our current thinking on the science surrounding new technologies,
how our regulatory framework may apply to new technology, and most
importantly, to hear from the public. On July 12, 2018, we held a
public meeting, ``Foods Produced Using Animal Cell Culture
Technology,'' to give the public an opportunity to provide comments
related to the production of foods using animal cell culture
technology. In this meeting, we discussed our expected involvement in
the oversight of products of cell culture technology and solicited
feedback from stakeholders. Building on this effort, on October 23 to
24, 2018, USDA and FDA hosted a joint public meeting entitled, ``Joint
Public Meeting on the Use of Cell Culture Technology to Develop
Products Derived From Livestock and Poultry.'' This meeting presented
the opportunity for FDA and USDA to hear from stakeholders about
various issues, including the labeling of food products comprised of or
containing cultured livestock and poultry cells.

II. Issues for Consideration and Request for Information

We invite comment in response to the questions below. Our use of
the term ``cultured seafood cells'' in these questions is intended to
distinguish between the foods, which are the subject of this document,
and conventionally produced seafood. It is not intended to establish or
suggest nomenclature for labeling purposes. The names and descriptions
in food labeling should be based on consumer understanding and usage as
described in section I.B.
We invite comment, particularly data and other evidence, about: (1)
Names or statements of identity for foods comprised of or containing
cultured seafood cells; (2) consumer understanding of terms that have
been suggested for the names or statements of identity of foods
comprised of or containing cultured seafood cells; and (3) how to
assess material differences between the foods that are the subject of
this document and conventionally produced foods. In responding to these
questions, please identify the question by its associated letter and
number (such as ``2(a)'') so that we can associate your response with a
specific question.
1. Should the name or statement of identity of foods comprised of
or containing cultured seafood cells inform consumers about how the
animal cells were produced? Please explain your reasoning.
2. What terms should be in the name or statement of identity of a
food comprised of or containing cultured seafood cells to convey the
nature or source of the food to consumers? (For example, possible terms
could be ``cell cultured'' or ``cell based'' or ``cell cultivated.'')
Please explain your reasoning and provide any studies or data about
consumer understanding of such terms.
a. How do these terms inform consumers of the nature or source of
the food?
b. If foods comprised of or containing cultured seafood cells were
to be labeled with the term ``culture'' or ``cultured'' in their names
or statements of identity (e.g., ``cell culture[d]''), would labeling
differentiation be necessary to distinguish these products from other
types of foods where the term ``culture'' or ``cultured'' is used (such
as ``aquaculture'')? Please explain your reasoning and provide any
studies or data about consumer understanding of such terms.
3. The names of many conventionally produced seafood products have
been established by common usage or by statute or regulation. Names are
also recommended for seafood species in The Seafood List.\3\ In FDA's
view, foods comprised of or containing cultured seafood cells are not
yet in the marketplace and, therefore, do not have common or usual
names established by common usage.
---------------------------------------------------------------------------

\3\ The Seafood List provides guidance to industry about
specificity in the naming of seafood sold in interstate commerce and
to assist manufacturers in labeling seafood products.
---------------------------------------------------------------------------

a. If you disagree with FDA's view, what are these names and what
evidence demonstrates that the names are commonly used and understood
by the American public for foods derived from cultured animal cells?
b. Should names for conventionally produced seafood products
established by common usage, statute, or regulation

[[Page 63280]]

be included in the names or statements of identity of food derived from
cultured seafood cells? Please explain your reasoning.
c. If so, is additional qualifying language necessary? What
qualifying terms or phrases would be appropriate? Please explain your
reasoning.
d. Do these names, with or without qualifying language, clearly
distinguish foods derived from seafood cell culture from conventionally
produced seafood? Please explain your reasoning.
e. Should FDA update The Seafood List to include foods comprised of
or containing cultured seafood cells? Please explain your reasoning.
4. Should terms that specify a certain type of seafood (such as
``fillet'' or ``steak'') be included in or accompany the name or
statement of identity of foods comprised of or containing cultured
animal cells?
a. Under what circumstances should these terms be used? What
information would they convey to consumers? For example, would such
terms convey the physical form or appearance of the food? Please
explain your reasoning. Additionally, please provide any studies or
data about consumer understanding of such terms when used to describe
foods comprised of or containing cultured seafood cells.
b. Would these terms be misleading to consumers? Please explain
your reasoning and provide any supporting studies or data.
5. When comparing conventionally produced seafood to foods
comprised of or containing cultured seafood cells, what attributes
(such as nutrition, taste, texture, or aroma) vary between the foods
and should FDA consider to be material to consumers' purchasing and
consumption decisions? Please explain your reasoning.
a. Are there other characteristics beyond nutritional attributes or
organoleptic properties that may be material differences? These could
relate either to cellular constituents or characteristics influenced by
the cell culture production process. Please be specific in your
response and explain your reasoning.

III. References

The following references are on display at the Dockets Management
Staff (see ADDRESSES) and are available for viewing by interested
persons between 9 a.m. and 4 p.m., Monday through Friday; they are also
available electronically at https://www.regulations.gov. FDA has
verified the website addresses, as of the date this document publishes
in the Federal Register, but websites are subject to change over time.

1. FDA, Statement from USDA Secretary Perdue and FDA Commissioner
Gottlieb on the Regulation of Cell Cultured Food Products from Cell
Lines of Livestock and Poultry, Nov. 16, 2018, available at https://www.fda.gov/news-events/press-announcements/statement-usda-secretary-perdue-and-fda-commissioner-gottlieb-regulation-cell-cultured-food-products.
2. Formal Agreement Between FDA and USDA Regarding Oversight of
Human Food Produced Using Animal Cell Technology Derived from Cell
Lines of USDA-amenable Species, March 7, 2019, available at https://www.fda.gov/food/domestic-interagency-agreements-food/formal-agreement-between-fda-and-usda-regarding-oversight-human-food-produced-using-animal-cell.

Dated: October 1, 2020.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2020-22140 Filed 10-6-20; 8:45 am]
BILLING CODE 4164-01-P